Drug Type Chemical drugs |
Synonyms Docetaxel nanoparticles, prostate cancer therapeutic(Janssen/Parabon NanoLabs), PJ-01 |
Target |
Action modulators, inhibitors |
Mechanism Tubulin modulators, Mitosis inhibitors, Tubulin polymerisation promoters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | United States | 04 Dec 2012 | |
| Prostatic Cancer | Preclinical | United States | 04 Dec 2012 |





